A positive association between T. gondii seropositivity and obesity

Frontiers in Public Health

Volumn 1, Issue DEC, 2013, Pages

  Reeves, Gloria M ^a   Mazaheri, Sara ^b   Snitker, Soren ^a   Langenberg, Patricia ^a   Giegling, Ina ^c   Hartmann, Annette M ^c   Konte, Bettina ^c   Friedl, Marion ^c   Okusaga, Olaoluwa ^d   Groer, Maureen W ^e   Mangge, Harald ^f   Weghuber, Daniel ^g   Allison, David B ^h   Rujescu, Dan ^c   Postolache, Teodor T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b St Elizabeths Hospital   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g Paracelsus Medical School   (Austria)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Body weight; Inflammation; Obesity; Parasitic infection; Toxoplasma gondii

Indexed keywords

EID: 85013696991     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2013.00073     Document Type: Article

References (46)

1. Kelley T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (2008) 32(9):1431-7. doi:10.1038/ijo.2008. 102
2. Wang C, Coups EJ. Causal beliefs about obesity and associated health behaviors: results from a population-based survey. Int J Behav Nutr Phys Act (2010) 7:19. doi:10.1186/1479-5868-7-19
3. Rao G, Burke LE, Spring BJ, Ewing LJ, Turk M, Lichtenstein AH, et al. New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation (2011) 124(10):1182-203. doi:10.1161/CIR.0b013e31822b9543
4. Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, Chatman J. Medicare's search for effective obesity treatments: diets are not the answer. Am Psychol (2007) 62(3):220-33. doi:10.1037/0003-066X.62.3.220
5. Dhurandhar NV. Infectobesity: obesity of infectious origin. J Nutr (2001) 131(10):2794S-7S.
6. Vasilakopoulou A, le Roux CW. Could a virus contribute to weight gain? Int J Obes (Lond) (2007) 31(9):1350-6. doi:10.1038/sj.ijo.0803623
7. Zupancic ML,Cantarel BL, Liu Z, Drabek EF, Ryan KA, Cirimotich S,et al.Analy-sis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS One (2012) 7(8):e43052. doi:10.1371/journal.pone.0043052
8. Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis (2011) 11(12):963-9. doi:10.1016/S1473-3099(11)70274-2
9. Lyons MJ, Faust IM, Hemmes RB, Buskirk DR, Hirsch J, Zabriskie JB. A virally induced obesity syndrome in mice. Science (1982) 216(4541):82-5. doi:10.1126/ science.7038878
10. Esposito S, Preti V, Consolo S, Nazzari E, Principi N. Adenovirus 36 infection and obesity. J Clin Virol (2012) 55(2):95-100. doi:10.1016/j.jcv.2012.06.009
11. van Ginneken V, Sitnyakowsky L, Jeffery JE. Infectobesity: viral infections (especially with human adenovirus-36: Ad-36) may be a cause of obesity. Med Hypotheses (2009) 72(4):383-8. doi:10.1016/j.mehy.2008.11.034
12. Yamada T,Hara K,Kadowaki T.Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS One (2012) 7(7):e42031. doi:10.1371/journal.pone.0042031
13. Lin WY, Dubuisson O, Rubicz R, Liu N,Allison DB, Curran JE, et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care (2013) 36(3):701-7. doi:10.2337/dc12-1089
14. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr (2009) 49(10):868-913. doi:10.1080/10408390903372599
15. Flegr J. Influence of latent toxoplasma infection on human personality, physiology, and morphology: pros and cons of the toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol (2013) 216(Pt 1):127-33. doi:10.1242/jeb073635
16. Flegr J, Stríž I. Potential immunomodulatory effects of latent toxoplasmosis in humans. BMC Infect Dis (2011) 11:274. doi:10.1186/1471-2334-11-274
17. Skariah S, McIntyre MK, Mordue DG. Toxoplasma gondii:determinantsoftachy-zoite to bradyzoite conversion. Parasitol Res (2010) 107(2):253-60. doi:10.1007/ s00436-010-1899-6
18. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 30(12-13):1217-58.
19. Hermes-Uliana C, Pereira-Severi LS, Luerdes RB, Franco CL, da Silva AV, Araújo EJ, et al. Chronic infection with Toxoplasma gondii causes myenteric neuroplasticity of the jejunum in rats. Auton Neurosci (2011) 160(1-2):3-8. doi:10.1016/j.autneu.2010.09.003
20. Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, Pletnikov MV. Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia Parasitol (Praha) (2010) 57(2):151-5.
21. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: a multinational epidemiological study. Scand J Infect Dis (2008) 40(5):381-6. doi:10.1080/00365540701708293
22. Serretti A, Mandelli L, Giegling I, Schneider B, Hartmann AM, Schnabel A, et al. HTR2C and HTR1A gene variantsin German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet (2007) 144B(3):291-9.
23. First MB, Spitzer RL, Gibbon M, Williams BW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). New York: New York State Psychiatric Institute (1990).
24. First MD, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/p, Version 2.0). New York: New York State Psychiatric Institute (1995).
25. Wittchen H, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview fur DSM-IV. Gottingen: Achse I und llHogrefe (1997).
26. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, et al. Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res (1995) 19(4):1018-23. doi:10.1111/j.1530-0277. 1995.tb00983.x
27. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis (2009) 197(12):905-8. doi:10.1097/NMD.0b013e3181c29a23
28. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull (2007) 33(3):729-36. doi:10.1093/schbul/sbl050
29. Hinze-Selch D, Däubener W, Erdag S, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) (2010) 57(2):129-35.
30. Hauner H, Bramlage P, Losch C, Steinhagen-Thiessen E, Schunkert H, Wasem J, et al. Prevalence of obesity in primary care using different anthropometric measures - results of the German metabolic and cardiovascular risk projects (GEMCAS). BMC Public Health (2008) 8:282. doi:10.1186/1471-2458-8-282
31. Lõhmus M,Moalem S, Björklund M. Leptin, a tool of parasites? Biol Lett (2012) 8(5):849-52. doi:10.1098/rsbl.2012.0385
32. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One (2011) 6(9):e23866. doi:10.1371/journal.pone.0023866
33. Boyle JP, Radke JR. A history of studies that examine the interactions of tox-oplasma with its host cell: emphasis on in vitro models. Int J Parasitol (2009) 39(8):903-14. doi:10.1016/j.ijpara.2009.01.008
34. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev (1998) 11(4):569-88.
35. Gigley JP, Fox BA, Bzik DJ. Cell-mediated immunitytoToxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication. J Immunol (2009) 182(2):1069-78.
36. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 25(1):4-7. doi:10.1016/j.it.2003.10.013
37. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 103(5):467-76. doi:10.1161/ CIRCRESAHA.108.177105
38. Wang Q, Perrard XD, Perrard JL, Mansoori A, Raya JL, Hoogeveen R, et al. Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with diet-induced obesity. Atherosclerosis (2011) 219(1):100-8. doi:10.1016/j.atherosclerosis.2011. 07.025
39. Priceman SJ, Kujawski M, Shen S,Cherryholmes GA, Lee H,Zhang C,et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A (2013) 110(32):13079-84. doi:10.1073/pnas.1311557110
40. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 29:415-45. doi:10.1146/annurev-immunol-031210-101322
41. Wong T, Hildebrandt MA, Thrasher SM, Appleton JA, Ahima RS, Wu GD. Divergent metabolic adaptations to intestinal parasitic nematode infection in mice susceptible or resistant to obesity. Gastroenterology (2007) 133(6):1979-88. doi:10.1053/j.gastro.2007.09.006
42. Newell DG, Koopmans M, Verhoef L, Duizer E, Aidara-Kane A, Sprong H, et al. Food-borne diseases - the challenges of 20 years ago still persist while new ones continue to emerge. Int J Food Microbiol (2010) 139(Suppl 1):S3-15. doi:10.1016/j.ijfoodmicro.2010.01.021
43. Mendes éA, Fonseca FG, Casério BM, Colina JP, Gazzinelli RT, Caetano BC. Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1. PLoS One (2013) 8(5):e63201. doi:10.1371/journal.pone.0063201
44. Hartmann K, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, et al. Toxoplasma gondii infection in cats: ABCD guidelines on preven-tion and management. J Feline Med Surg (2013) 15(7):631-7. doi:10.1177/ 1098612X13489228
45. Jürges H. True health vs response styles: exploring cross-country differences in self-reported health. Health Econ (2007) 16(2):163-78. doi:10.1002/hec.1134
46. Bolton-Smith C, Woodward M, Tunstall-Pedoe H, Morrison C. Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 54(2):143-8. doi:10.1136/jech.54.2.143